Home › This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
 

Keywords :   


This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market

2015-02-02 16:11:55| Chemicals - Topix.net

If Ophthotech's late-stage trials pan out, Ophthotech could have a billion-dollar blockbuster drug on its hands. First, a bit of background The drug Ophthotech is developing is Fovista, a possible treatment for wet-stage, age-related macular degeneration -- one of the most common forms of vision loss among aging Americans.

Tags: this share market capture

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »